Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Antifungal Susceptibility
100%
Colombia
73%
Epidemiology
72%
Candida Albicans (C. albicans)
66%
Invasive Candidiasis
66%
Genetic Diversity
66%
Aurès
66%
C.glabrata
42%
Antifungal Resistance
34%
Rare Yeasts
33%
Epidemiological Characteristics
33%
University Hospital
33%
Infected Patients
33%
Mayors
33%
Molecular Identification
33%
Indigenous Women
33%
Co-infection
33%
Multiple Pathogens
33%
Latin America (LATAM)
33%
Tuberculosis
33%
Autoimmune Hemolytic Anemia
33%
C.tropicalis
31%
Candida Glabrata
24%
Parapsilosis
24%
Epidemiological Data
24%
Invasive Infection
24%
Fluconazole
20%
Candida Guilliermondii
17%
Clonal Dispersal
17%
Candida Infection
17%
Ribosomal DNA
17%
Candida Tropicalis
17%
Candida Parapsilosis
17%
Healthcare Settings
17%
Clinical Impact
17%
Candida Species
17%
Candida Dubliniensis
17%
Yeast Species
16%
Non-albicans
13%
High Mortality
13%
Caspofungin
13%
Indigenous Peoples
13%
Flucytosine
13%
Candida Isolates
13%
Immunosuppressive Therapy
13%
Amphotericin B
12%
Trichosporon Asahii
11%
Comorbidity Treatment
11%
Overall Mortality
11%
Critically Ill Patients
11%
Resistant Isolate
11%
Antibiotics
11%
Type 1 Diabetes Mellitus (T1DM)
11%
Fungemia
11%
Aplasia
6%
General Mortality
6%
Myelotoxicity
6%
Treatment Interventions
6%
Multiple Causes
6%
Preventive Screening
6%
Global Surveillance
6%
Mold Contamination
6%
Aging Treatment
6%
Morbidity Rate
6%
Focus of Attention
6%
Antifungal Therapy
6%
Local Surveillance
6%
Statistical Analysis
6%
Spur
6%
Mortality Risk
6%
Disseminated Infection
6%
Secondary Infection
6%
Therapy Interventions
6%
Epidemiological Indicators
6%
Etiological Agents
6%
Public Health Authorities
6%
Leading Causes of Death
6%
Azoles
6%
Prevention Management
6%
Antifungal Drugs
6%
Underlining
6%
Treatment Therapy
6%
Predisposing Factors
6%
Clinical Complications
6%
Multidrug-resistant Microorganisms
6%
Broth Microdilution
6%
Echinocandins
6%
Mortality Rate
6%
Klebsiella Pneumoniae (K. pneumoniae)
6%
Mycobacterial Infection
6%
Medical Intervention
6%
Voriconazole
6%
Old Age
6%
Multidrug-resistant Pathogens
6%
Autopsy
6%
Vulnerable Communities
6%
Low Genetic Diversity
6%
Invasive Aspergillosis
6%
High Incidence
6%
Staphylococcus Aureus
6%
Vitek 2
6%
MALDI-TOF
6%
Acquired Resistance
6%
Pulmonary Tuberculosis
6%
Bogota Colombia
6%
Risk Conditions
6%
Rhodotorula mucilaginosa
5%
Seriously Ill Patients
5%
Crude Mortality
5%
Trichosporon Infection
5%
Rhodotorula
5%
Clinical Data
5%
Antibiotic Use
5%
Latin American Countries
5%
Risk of Death
5%
Leukemia
5%
High Risk
5%
Diagnostic Methodology
5%
Demographic Data
5%
Clinical Significance
5%
Saccharomyces Cerevisiae
5%
Neonate
5%
Opportunistic Yeasts
5%
Common Species
5%
Central Venous Catheter
5%
Systemic Infection
5%
Immunology and Microbiology
Antifungal Susceptibility
100%
Genetic Variability
66%
Candida
66%
Antifungal Resistance
56%
Rhodotorula
33%
Trichosporon
33%
Trichosporon asahii
33%
Rhodotorula mucilaginosa
33%
baker's yeast
33%
Epidemiological Data
21%
Meyerozyma guilliermondii
15%
Candida Dubliniensis
15%
Candida parapsilosis
15%
Candida tropicalis
15%
Candida glabrata
15%
Candida Auris
13%
Candida albicans
13%
Comorbidity
8%
Mould
6%
Broth Dilution
6%
Mortality Rate
6%
Pharmacology, Toxicology and Pharmaceutical Science
Candida
66%
Invasive Candidiasis
66%
Infection
44%
Fluconazole
33%
Resistance to Antifungal Agent
33%
Candida Auris
22%
Caspofungin
22%
Candida albicans
22%
Flucytosine
22%
Meyerozyma guilliermondii
22%
Candida parapsilosis
22%
Candida tropicalis
22%
Candida Dubliniensis
22%
Candidiasis
22%
Ribosome DNA
22%
Candida glabrata
22%
Voriconazole
11%
Pyrrole Derivative
11%
Mould
11%
Echinocandin
11%
Mortality Rate
11%
Amphotericin B
11%
Antifungal Agent
11%
Comorbidity
11%
Diabetes Mellitus
11%
Antibiotics
11%